Satoko Ito, MD, PhD

Associate Research Scientist

DownloadHi-Res Photo

About

Titles

Associate Research Scientist

Biography

Satoko Ito, MD, PhD, is a Postdoctoral Associate with a research focus in quantitative decision science. Dr. Ito is a trained hematologist and palliative care physician with 10 years of attending clinical practice. She obtained her PhD in Epidemiology in 2021 from Kyoto University. Dr. Ito is the Decision Analytic Modeling Research Lead in the Goshua Lab, the first quantitative decision analytic modeling lab with a focus in hematology-oncology in the United States.

Last Updated on February 14, 2023.

Education & Training

PhD: Kyoto University, Epidemiology (2021)

MD: Okayama University, Medicine (2005)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Satoko Ito's published research.

George Goshua, MD, SM, FACP
View Full Profile
View 14 Common Publications
Manraj Singh Sra, MBBS
View Full Profile
View 10 Common Publications
Harlan Krumholz, MD, SM
View Full Profile
View 9 Common Publications
Quinton (Ding Quan) Ng, PhD, BSc (Hon)
View Full Profile
View 8 Common Publications
Robert Bona, MD
View Full Profile
View 4 Common Publications
Alfred Lee, MD, PhD
View Full Profile
View 3 Common Publications

Publications

2026

Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds
Wang D, Sra M, Ng D, Tadepalli A, Rinaldi K, Ito S, Cuker A, Goshua G. Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds. Blood Advances 2026, 10: 5644-5652. PMID: 42206692, PMCID: PMC13499173, DOI: 10.1182/bloodadvances.2026020143.
Peer-Reviewed Original Research
Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A
Lim M, Ito S, Goshua G, Chaiyakunapruk N, Yoo M, Nelson R. Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels Thrombosis & Hemostasis 2026, 3: 100195. PMID: 42733552, PMCID: PMC13571228, DOI: 10.1016/j.bvth.2026.100195.
Peer-Reviewed Original Research
Duffy Testing to Benefit Children’s Population Health: A Cost-Effectiveness Analysis
Merz L, Ito S, Sra M, Ng D, Walkovich K, Okam Achebe M, Frustace P, van Havre N, Goshua G. Duffy Testing to Benefit Children’s Population Health: A Cost-Effectiveness Analysis. Blood Advances 2026 PMID: 42486669, DOI: 10.1182/bloodadvances.2026019827.
Peer-Reviewed Original Research
Barriers to effective first-line treatment for women with iron deficiency
Rinaldi K, Ng D, Tadepalli A, Ito S, Goshua G, Wang D. Barriers to effective first-line treatment for women with iron deficiency. Expert Review Of Hematology 2026, 19: 799-801. PMID: 42212667, DOI: 10.1080/17474086.2026.2683026.
Commentaries, Editorials and Letters
JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis
Lam B, Ito S, Ryu J, O'Sullivan K, Potnis K, Lu R, Bidikian A, Ng D, Singh R, Deter A, Carfagnini C, Bechara S, Kandula M, Do N, Fillmore N, Freed J, Patell R, La J, Goshua G. JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis. American Journal Of Hematology 2026, 101: 2412-2416. PMID: 42227164, PMCID: PMC13428362, DOI: 10.1002/ajh.70390.
Commentaries, Editorials and Letters
Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis
Chetlapalli K, Ito S, Ng D, Sra M, Wang D, Krumholz H, Krishnamurti L, Pandya A, Goshua G. Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis. Blood 2026, 148: 896-909. PMID: 42227898, PMCID: PMC13507984, DOI: 10.1182/blood.2025032290.
Peer-Reviewed Original Research
This study investigates the cost-effectiveness of haploidentical stem cell transplantation, gene therapy, and standard care for sickle cell disease, showing transplantation offers the best value globally.
Full Summary
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia
Ito S, Potnis K, Ng D, Patel K, Sra M, Shallis R, Podoltsev N, Kewan T, Stempel J, Mendez L, Huntington S, Stahl M, Zeidan A, Bewersdorf J, Goshua G. Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia. Blood Red Cells & Iron 2026, 2: 100076. PMID: 42077391, PMCID: PMC13134686, DOI: 10.1016/j.brci.2026.100076.
Peer-Reviewed Original Research
This study investigates how trainee-led teams developed updated consensus guidelines for managing peritoneal surface malignancies, demonstrating effective collaboration models for complex medical evidence synthesis.
Full Summary
"Cost-Effectiveness and Budget Impact of Facial Feminization Surgery".
Glaeser-Khan S, Shen Y, Wolbert T, Mukherjee T, Goshua G, Ito S, Alperovich M. "Cost-Effectiveness and Budget Impact of Facial Feminization Surgery". Plastic & Reconstructive Surgery 2026 PMID: 41940840, DOI: 10.1097/prs.0000000000013106.
Peer-Reviewed Original Research
Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding
Wang D, Sra M, Ito S, Ng D, Glaeser-Khan S, Wang D, Hirniak S, Lee A, Cuker A, Goshua G. Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding. Blood Advances 2026, 10: 1508-1517. PMID: 41504430, PMCID: PMC12952766, DOI: 10.1182/bloodadvances.2025018315.
Peer-Reviewed Original Research
MeSH Keywords

2025

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis
Glaeser-Khan S, Ito S, Sra M, Richmond R, Bona R, Krumholz H, Croteau S, Cuker A, Goshua G. Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis. Blood Advances 2025, 9: 6237-6245. PMID: 40795232, PMCID: PMC12744270, DOI: 10.1182/bloodadvances.2025016822.
Peer-Reviewed Original Research

See All Publications

ORCID
0000-0003-4430-1860

News

Get In Touch

Contacts

satoko.ito@yale.edu

Satoko Ito, MD, PhD

About

Titles

Biography

Education & Training

Research

Research at a Glance

Yale Co-Authors

Publications Timeline

George Goshua, MD, SM, FACP

Manraj Singh Sra, MBBS

Harlan Krumholz, MD, SM

Quinton (Ding Quan) Ng, PhD, BSc (Hon)

Robert Bona, MD

Alfred Lee, MD, PhD

Publications

2026

Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds

Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A

Duffy Testing to Benefit Children’s Population Health: A Cost-Effectiveness Analysis

Barriers to effective first-line treatment for women with iron deficiency

JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis

Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis

Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia

"Cost-Effectiveness and Budget Impact of Facial Feminization Surgery".

Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding

2025

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

ORCID

News

News

Drug Offers Cost-Effective Protection for Newborns with Genetic Bleeding Disorder

New Research Sheds Light on Equitable Treatment Options for Pediatric Patients With Sickle Cell Disease

Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease

Get In Touch

Contacts